InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Greenfield Andrew J, Vice-Président, Directeur Commercial. Insider active across 1 company, notably ABIOMED INC. Aggregated, 17 filings have been recorded. Activity tracked since 16 May 2021. The latest transaction was filed on 22 December 2022 (Disposition). Regulator: SEC (Form 4). The full history is free.
Declarations17 total
23,484 shares0Common Stock, $.01 par valueSEC:0001415889-22-013015:0
14 shares0Common Stock, $.01 par valueSEC:0001415889-22-012843:0
1,548 shares@ US$373.9964.1% of flowCommon Stock, $.01 par valueSEC:0001415889-22-011183:0
34 shares0Common Stock, $.01 par valueSEC:0001415889-22-010224:0
5,348 shares0Common Stock, $.01 par valueSEC:0001415889-22-005928:0
302 shares@ US$249.1921.1% of flowCommon Stock, $.01 par valueSEC:0001415889-22-005795:0
25 shares0Common Stock, $.01 par valueSEC:0001415889-22-003744:0
6,975 shares0Common Stock, $.01 par valueSEC:0001179110-21-009904:0
6,975 shares0Common Stock, $.01 par valueSEC:0001179110-21-009904
26 shares0Common Stock, $.01 par valueSEC:0001179110-21-009163:0
26 shares0Common Stock, $.01 par valueSEC:0001179110-21-009163
366 shares@ US$284.5825.6% of flowCommon Stock, $.01 par valueSEC:0001179110-21-006231
366 shares@ US$284.5825.6% of flowCommon Stock, $.01 par valueSEC:0001179110-21-006231:0
2,000 shares0Common Stock, $.01 par valueSEC:0001179110-21-006011:0
2,000 shares0Common Stock, $.01 par valueSEC:0001179110-21-006011
208 shares@ US$268.5613.8% of flowCommon Stock, $.01 par valueSEC:0001179110-21-005512
208 shares@ US$268.5613.8% of flowCommon Stock, $.01 par valueSEC:0001179110-21-005512:0
17 of 17 declarations
About Greenfield Andrew J
Andrew J. Greenfield is the Vice President and Chief Commercial Officer of ABIOMED INC. In this role, he is responsible for the commercial strategy and growth initiatives, aiming to optimize the company's operations.
